1Tedeschi E, Menegazzi M, Yao Y, et al. Green tea inhibits human inducible nitric-oxide synthase expression by down- regulating signal transducer and activator of transcription-1 alpha activation. Mol Pharmacol, 2004, 65 : 111 - 120.
2Weinreb O, Mandel S, Amit T. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's disease. J Nutr Biochem, 2004, 15 : 506 -516.
3Guo S, Yan J, Yang T, et al. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway. Biol Psychiatry, 2007, 62 : 1353-1362.
4Chan YC, Hosoda K, Tsai CJ, et al. Favorable effects of tea on reducing the cognitive deficits and brain morphological changes in senescence-accelerated mice. J Nutr Sci Vitaminol, 2006, 52 : 266-273.
5Suzuki M, Tabuchi M, Ikeda M, et al. Protective effects of green tea catechins on cerebral ischemic damage. Med Sci Monit, 2004, 10 : 166-174.
6Guo SH, Erwan B, Zhao BL. Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radical Biol Med, 2005, 9 : 682 - 695.
7Lee SJ, Lee KW. Protective effect of epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells. Biol Pharm Bull, 2007, 30 : 1369 - 1373.
8Jung JY, Han CR, Jeong YJ, et al. Epigallocatechin gallate inhibits nitric oxide-induced apoptosis in rat PC12 cell. Neurosci Lett, 2007, 411:222-227.
9Hou RR, Chen JZ, Chen H, et al. Neuroprotective effects of (-) -epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis in PC12 cells. Cell Biol Int, 2008, 32 : 22-30.
10Li R, Peng N, Li XP, et al. Epigalloeatechin gallate regulates dopamine transporter internalization via protein kinase C-dependent pathway. Brain Res, 2006, 1097 : 85 -89.
2Bell DR,Jorgensen P, Christophel EM,et al.Malaria risk: estimation of the malaria burden[J].Nature,2005,437(1 ):E3-E4.
3Yang HL,Liu DQ,Yang YM,et al.In vitro sensitivity of Plasmodium falciparum to eight antimalarials in China-Myanmar and China- Lao PDR border areas[J].Southeast Asian J Trop Meal Public Health, 1997,28(3):460-464.
4Yang HL,Liu DQ,Yang YM,et al.Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China[J].Trans R Soc Trop Med Hyg,2003,97(2):226-228.
5Jambou R,Legrand E,Niang M,et al.Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6[J]. Lancet,2005,366(9501):1960- 1963.
6Riekmann KH, Sax LJ,Cambell GH,et al .Drug sensitivity of Plasmo- dium f alciparum.An in vitro microtechnique[J] .Lancet, 1978,1 (1) : 22 - 23.
8Severini C,Menegon M,Sannella AR,et al.Prevalence of pfcrt point mutations and level of cloroquine resistance in Plasmodium falciparum isolates from Africa,lnfect[J].Genet Evol,2006,6(2): 262-268.